Exide Industries Ltd
NSE: EXIDEINDCompany page on Cofacto
Open the Exide Industries Ltd page

Exide Industries Limited (EXIDEIND) Q2 Results FY27 Preview: Date, Time, Expectations & Key Things To Watch

Cofacto Research Published October 30, 2026 6 min read

Exide Industries makes lead-acid batteries for automotive, industrial and home applications, and has just commissioned its first 6 GWh lithium-ion cell plant at Devanahalli via subsidiary EESL. This quarter's print will speak to whether the core EBITDA margin holds management's 'plus 12% to plus 13%' corridor amid a weaker rupee and elevated sulphur costs, and when the newly commissioned Li-ion plant starts booking revenue.

Quick Details
Results dateNovember 04, 2026
QuarterQ2 FY 2026-2027
Previous quarter revenueRs. 5,305.05 Cr (standalone, +17.6% YoY)
Previous quarter PATRs. 407.26 Cr (standalone, +27.1% YoY)
Previous quarter EBITDA margin12.4%
Market capRs. 28,509.23 Cr
CMPRs. 335.5

Exide Industries Limited Q2 Results Date and Time

Per the company's September 29, 2026 intimation, the Board will meet on Wednesday, November 4, 2026 to approve unaudited standalone and consolidated financial results for the quarter and half-year ending September 30, 2026. The trading window reopens on Saturday, November 7, 2026.

What to expect from Exide Industries Limited's Q2 FY27 results

The quarter's setup points to reported growth ahead of management's high-single to low-double-digit core outlook for FY27, helped by a flagged low-base advantage — Q2 FY26 revenue fell 2% YoY on the monsoon and GST 2.0 solar-inverter hit — with FADA recording best-ever July retail (+25.89% YoY) and a best-ever September for 2W (+33.08%).

On margins, LME lead averaged $1,842.5 (Jul), $1,855.7 (Aug) and $1,872.9 (Sep), below Q1's May–June levels and down 4.19% YoY in September, meeting management's condition that 'we only hope lead remains at the current level', while the rupee's slide from the Rs. 90 management referenced to about Rs. 95–96 by mid-September is the main new cost pressure.

Q1 FY27's 12.4% EBITDA margin already sits inside the 'plus 12% to plus 13%' corridor and 110 bps above the FY26 full-year margin of 11.3%, with the pending Q2 price decision and OEM pass-through (which lags one quarter) the swing factors. The Li-ion story goes live this quarter: Phase-I 6 GWh was commissioned on September 23, 2026, first cell samples were dispatched in Q1, and management has promised a material disclosure on significant revenue recognition during FY27, with utilization guided at 25–30% for the year.

The call is also likely to cover the PLI application that follows the official production declaration, EESL funding tranches that took cumulative investment to Rs. 5,352.23 Cr, and export uncertainty that management expects to persist through H1 FY27.

Key Things To Watch

Margin corridor tracking vs lead and rupee moves: Whether the core margin holds after Q1's 12.4% print.

  • Core margin corridor of 'plus 12% to plus 13%' (open-ended) — Q1 FY27 printed 12.4%; check whether Q2 holds the corridor amid lead/rupee moves and the pending Q2 price decision
  • FY27 margin improvement of 100–150 bps (contingent on LME support) — Q1 FY27's 12.4% already sits 110 bps above the FY26 full-year margin of 11.3%
  • Whether further price corrections followed Q1's 4–6% YoY, and pass-through of sulfuric acid (Rs. 74–75/kg in April), lead and rupee pressure

Li-ion ramp: revenue, utilization and Line 4: First full quarter after the September 23, 2026 commissioning of the 6 GWh Phase-I plant.

  • Li-ion revenue commencement during FY27 — watch for the promised material disclosure on significant revenue recognition and the official production-declaration/subsidy (PLI) application
  • Utilization/yield ramp: 25–30% utilization guided for FY27; 90% yield and >85% utilization targets precede any financial guidance
  • Line 4 (LFP, 4W OEM-dedicated) commissioning by fiscal year-end and 2W commercial production expected by FY27; updates on 4W OEM engagement (1–2 majors)

EESL funding pace: Tranche deployment against the FY27 board approval.

  • Rs. 1,400 Cr board-approved for FY27; Rs. 100 Cr infused in July, then ~Rs. 200 Cr (Aug 18), ~Rs. 100 Cr (Sep 29) and ~Rs. 150 Cr (Oct 27) — cumulative investment now Rs. 5,352.23 Cr; check for further tranches

Base effect, exports and government tenders: Whether reported growth clears the core outlook on a favorable base.

  • Management flagged a low-base advantage for Q2 FY27 (Q2 FY26 revenue fell 2% YoY) — test whether reported growth exceeds the high-single to low-double-digit core outlook
  • Exports expected to stay uncertain through H1 FY27 (now 5–6% of business vs 8% a few quarters ago); government tenders expected to pick up in H2 — check for early signs
  • China VAT removal from January 1, 2027 — impact on import landed costs and the import-parity pricing path

Unexplained items and partnership updates: Open items from the Q1 call and recent corporate actions.

  • Any explanation of Q1 FY27's total comprehensive income drop (Rs. 294.95 Cr vs Rs. 1,282.43 Cr year-ago) and any first-time quantification of the EPR accrual
  • Hyundai co-investment line — confirmation it remains outside the current fiscal year (management declined timelines/financials as material disclosure)
  • ExCom Energy Solutions GmbH partnership (signed September 15, 2026) — any disclosed financial terms or initial EEA orders (none disclosed to date)

Frequently Asked Questions

How fast did Exide Industries grow in Q1 FY27?

Standalone revenue rose 17.6% YoY to Rs. 5,305.05 Cr in Q1 FY27, with automotive OEM growing over 25% for a third consecutive quarter and home inverters and solar up over 20% YoY. Management cautioned against extrapolating this pace due to a favorable base effect in auto OEM, while flagging a low-base advantage for Q2.

When will Exide's lithium-ion plant start generating revenue?

Phase-I of 6 GWh at Devanahalli, Bengaluru was commissioned on September 23, 2026, and the company is on track to commence revenue generation during FY27. Management has said any significant revenue recognition will be a material disclosure.

What is Exide's EBITDA margin guidance for FY27?

Management has indicated a core lead-acid EBITDA margin corridor of 'plus 12% to plus 13%' on an open-ended basis, with Q1 FY27 printing 12.4%. It also stated an improvement of another 100–150 bps by FY27, provided there is support from LME lead.

How much has Exide invested in its lithium-ion subsidiary EESL so far?

Cumulative investment in EESL reached Rs. 5,352.23 Cr after the October 27, 2026 tranche of Rs. 150 Cr, with Exide holding 100% shareholding. The board has approved up to Rs. 1,400 Cr of infusion for FY27, and the total investment plan is Rs. 7,000 Cr for 12 GWh.

What is the status of Exide's solar business growth target?

The target of crossing Rs. 1,000 Cr in solar revenue by FY26 was met, with the segment crossing the Rs. 1,000 crore mark for the full year. Management has also stated a solar revenue goal of Rs. 1,500 Cr in 2–3 years, stated in November 2025.

Disclaimer: This earnings preview is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.

Powered by Cofacto — AI research platform for Indian stocks, every claim cited from primary filings

Login Now